For most people, the word cancer implies that there’s a tumor or mass growing somewhere in the body. However, contrary to ...

Last November, longtime Claremont resident Lou Berrio was diagnosed with acute myeloid leukemia, a type of cancer that tricks ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

Red blood cells are the most abundant cells in the body. It has long been known that when red blood cells break down or anemia occurs due to bleeding, the hormone erythropoietin (EPO) increases, ...

assessing the efficacy of venetoclax plus decitabine as a bridge to allogeneic HSCT in 93 older White patients (aged 60–75 years) with intermediate-risk or high-risk acute myeloid leukaemia who were ...

Notably, 30,000 of these cases are in children. Blood cancers primarily fall into three main categories: leukemia, lymphoma, ...

Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

We came across a bullish thesis on Sellas Life Sciences Group Inc (SLS) on ValueInvestorsClub by ContraMundem. In this ...

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

Learn the key differences between lymphoma and leukemia in this World Lymphoma Awareness Day 2024 article. Understand their ...